This report contains market size and forecasts of Hodgkin Lymphoma Treatment in Global, including the following market information:
Global Hodgkin Lymphoma Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hodgkin Lymphoma Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hodgkin Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hodgkin Lymphoma Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hodgkin Lymphoma Treatment Market Segment Percentages, By Type, 2020 (%)
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others
China Hodgkin Lymphoma Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Hodgkin Lymphoma Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Research Center
Global Hodgkin Lymphoma Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Hodgkin Lymphoma Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Hodgkin Lymphoma Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hodgkin Lymphoma Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Merck & Co., Inc.
Mirati Therapeutics Inc.
Molecular Templates Inc.
NantKwest, Inc.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hodgkin Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hodgkin Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hodgkin Lymphoma Treatment Overall Market Size
2.1 Global Hodgkin Lymphoma Treatment Market Size: 2021 VS 2027
2.2 Global Hodgkin Lymphoma Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hodgkin Lymphoma Treatment Players in Global Market
3.2 Top Global Hodgkin Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Hodgkin Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hodgkin Lymphoma Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hodgkin Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hodgkin Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Hodgkin Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Hodgkin Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hodgkin Lymphoma Treatment Market Size Markets, 2021 & 2027
4.1.2 Alocrest
4.1.3 ANK Program
4.1.4 Azacitidine
4.1.5 BMS-986016
4.1.6 BPX-501
4.1.7 Others
4.2 By Type - Global Hodgkin Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Hodgkin Lymphoma Treatment Revenue, 2016-2021
4.2.2 By Type - Global Hodgkin Lymphoma Treatment Revenue, 2022-2027
4.2.3 By Type - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hodgkin Lymphoma Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.2 By Application - Global Hodgkin Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Hodgkin Lymphoma Treatment Revenue, 2016-2021
5.2.2 By Application - Global Hodgkin Lymphoma Treatment Revenue, 2022-2027
5.2.3 By Application - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Hodgkin Lymphoma Treatment Market Size, 2021 & 2027
6.2 By Region - Global Hodgkin Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Hodgkin Lymphoma Treatment Revenue, 2016-2021
6.2.2 By Region - Global Hodgkin Lymphoma Treatment Revenue, 2022-2027
6.2.3 By Region - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hodgkin Lymphoma Treatment Revenue, 2016-2027
6.3.2 US Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.3.3 Canada Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.3.4 Mexico Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hodgkin Lymphoma Treatment Revenue, 2016-2027
6.4.2 Germany Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4.3 France Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4.4 U.K. Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4.5 Italy Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4.6 Russia Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.4.8 Benelux Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hodgkin Lymphoma Treatment Revenue, 2016-2027
6.5.2 China Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.5.3 Japan Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.5.4 South Korea Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.5.6 India Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hodgkin Lymphoma Treatment Revenue, 2016-2027
6.6.2 Brazil Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.6.3 Argentina Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hodgkin Lymphoma Treatment Revenue, 2016-2027
6.7.2 Turkey Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.7.3 Israel Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Hodgkin Lymphoma Treatment Market Size, 2016-2027
6.7.5 UAE Hodgkin Lymphoma Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Cell Medica Limited
7.1.1 Cell Medica Limited Corporate Summary
7.1.2 Cell Medica Limited Business Overview
7.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Major Product Offerings
7.1.4 Cell Medica Limited Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.1.5 Cell Medica Limited Key News
7.2 Cellular Biomedicine Group, Inc.
7.2.1 Cellular Biomedicine Group, Inc. Corporate Summary
7.2.2 Cellular Biomedicine Group, Inc. Business Overview
7.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.2.4 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.2.5 Cellular Biomedicine Group, Inc. Key News
7.3 Constellation Pharmaceuticals, Inc.
7.3.1 Constellation Pharmaceuticals, Inc. Corporate Summary
7.3.2 Constellation Pharmaceuticals, Inc. Business Overview
7.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.3.4 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.3.5 Constellation Pharmaceuticals, Inc. Key News
7.4 Curis, Inc.
7.4.1 Curis, Inc. Corporate Summary
7.4.2 Curis, Inc. Business Overview
7.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.4.4 Curis, Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.4.5 Curis, Inc. Key News
7.5 Faron Pharmaceuticals Oy
7.5.1 Faron Pharmaceuticals Oy Corporate Summary
7.5.2 Faron Pharmaceuticals Oy Business Overview
7.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Major Product Offerings
7.5.4 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.5.5 Faron Pharmaceuticals Oy Key News
7.6 Fate Therapeutics, Inc.
7.6.1 Fate Therapeutics, Inc. Corporate Summary
7.6.2 Fate Therapeutics, Inc. Business Overview
7.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.6.4 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.6.5 Fate Therapeutics, Inc. Key News
7.7 Gamida Cell Ltd.
7.7.1 Gamida Cell Ltd. Corporate Summary
7.7.2 Gamida Cell Ltd. Business Overview
7.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Major Product Offerings
7.4.4 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.7.5 Gamida Cell Ltd. Key News
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Corporate Summary
7.8.2 Gilead Sciences, Inc. Business Overview
7.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.8.4 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.8.5 Gilead Sciences, Inc. Key News
7.9 Incyte Corporation
7.9.1 Incyte Corporation Corporate Summary
7.9.2 Incyte Corporation Business Overview
7.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Major Product Offerings
7.9.4 Incyte Corporation Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.9.5 Incyte Corporation Key News
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Corporate Summary
7.10.2 Merck & Co., Inc. Business Overview
7.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.10.4 Merck & Co., Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.10.5 Merck & Co., Inc. Key News
7.11 Mirati Therapeutics Inc.
7.11.1 Mirati Therapeutics Inc. Corporate Summary
7.11.2 Mirati Therapeutics Inc. Business Overview
7.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.11.4 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.11.5 Mirati Therapeutics Inc. Key News
7.12 Molecular Templates Inc.
7.12.1 Molecular Templates Inc. Corporate Summary
7.12.2 Molecular Templates Inc. Business Overview
7.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.12.4 Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.12.5 Molecular Templates Inc. Key News
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Corporate Summary
7.13.2 NantKwest, Inc. Business Overview
7.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.13.4 NantKwest, Inc. Hodgkin Lymphoma Treatment Revenue in Global (2016-2021)
7.13.5 NantKwest, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hodgkin Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Hodgkin Lymphoma Treatment Market Drivers in Global Market
Table 3. Hodgkin Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Hodgkin Lymphoma Treatment in Global Market
Table 5. Top Hodgkin Lymphoma Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hodgkin Lymphoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hodgkin Lymphoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hodgkin Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Hodgkin Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hodgkin Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Merck & Co., Inc.
Mirati Therapeutics Inc.
Molecular Templates Inc.
NantKwest, Inc.